Anti-tumour immune responses are led by lymphocytes, including cytotoxic CD8+ T cells, CD4+ helper T cells, and natural killer (NK) cells, with the help of pro-inflammatory macrophages (M1) and dendritic cells. The gene discussed is CD8A; the disease is neoplasm.